BioSpace News Archive

Press Releases

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years

October 28, 2025
·
22 min read
Press Releases

Hengrui Pharma Reports Steady Growth in Q3 2025 Driven by Innovation and Global Expansion

October 28, 2025
·
1 min read
Press Releases

Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis

October 28, 2025
·
11 min read
Press Releases

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

October 28, 2025
·
13 min read
Press Releases

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

October 28, 2025
·
9 min read
Press Releases

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

October 28, 2025
·
5 min read
Press Releases

Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)

October 28, 2025
·
6 min read
Press Releases

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

October 28, 2025
·
6 min read
Press Releases

Positive Phase III Results for Genentech’s Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome

October 28, 2025
·
13 min read
Press Releases

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing

October 28, 2025
·
3 min read